Tailored approach to the treatment of pulmonary mycobacteriosis in patients with cystic fibrosis

Abstract

Diagnosis, treatment, and follow-up of children with cystic fibrosis and pulmonary mycobacteriosis pose a challenge due to lack of scientifically justified clinical recommendations on patient management. The article provides two clinical observations, illustrating a personalized approach to administration of antibacterial therapy to children with cystic fibrosis and bronchopulmonary comorbidity caused by nontuberculous mycobacteria. Clinical, microbiological, and radiological study results were interpreted to define treatment tactics. Key words: children, cystic fibrosis, pulmonary mycobacteriosis, nontuberculous mycobacteria